Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Lamivudine
Lamivudine+Oxymatrine Capsules
Locations
1
China
the second hospital of Nanjing
Nanjing, Jiangsu, China
Primary Completion Date
February 1, 2014
Last Updated
July 29, 2014
NCT06671093
NCT06885710
NCT06263959
NCT06295328
NCT02883647
NCT04139850
Lead Sponsor
Southeast University, China
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions